143 related articles for article (PubMed ID: 34375106)
1. Discovery of High-Affinity Inhibitors of the BPTF Bromodomain.
Lu T; Lu H; Duan Z; Wang J; Han J; Xiao S; Chen H; Jiang H; Chen Y; Yang F; Li Q; Chen D; Lin J; Li B; Jiang H; Chen K; Lu W; Lin H; Luo C
J Med Chem; 2021 Aug; 64(16):12075-12088. PubMed ID: 34375106
[TBL] [Abstract][Full Text] [Related]
2. Discovery of selective BPTF bromodomain inhibitors by screening and structure-based optimization.
Xiong L; Mao X; Guo Y; Zhou Y; Chen M; Chen P; Yang S; Li L
Biochem Biophys Res Commun; 2021 Mar; 545():125-131. PubMed ID: 33548625
[TBL] [Abstract][Full Text] [Related]
3. New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition.
Zahid H; Buchholz CR; Singh M; Ciccone MF; Chan A; Nithianantham S; Shi K; Aihara H; Fischer M; Schönbrunn E; Dos Santos CO; Landry JW; Pomerantz WCK
J Med Chem; 2021 Sep; 64(18):13902-13917. PubMed ID: 34515477
[TBL] [Abstract][Full Text] [Related]
4. New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development.
Ycas PD; Zahid H; Chan A; Olson NM; Johnson JA; Talluri SK; Schonbrunn E; Pomerantz WCK
Org Biomol Chem; 2020 Jul; 18(27):5174-5182. PubMed ID: 32588860
[TBL] [Abstract][Full Text] [Related]
5. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer.
Xu J; Wang Q; Leung ELH; Li Y; Fan X; Wu Q; Yao X; Liu L
Front Med; 2020 Feb; 14(1):60-67. PubMed ID: 31104301
[TBL] [Abstract][Full Text] [Related]
6. Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF.
Zahid H; Olson NM; Pomerantz WCK
Curr Opin Chem Biol; 2021 Aug; 63():57-67. PubMed ID: 33706239
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of NVS-BPTF-1 and evaluation of its biological activity.
Mélin L; Calosing C; Kharenko OA; Hansen HC; Gagnon A
Bioorg Med Chem Lett; 2021 Sep; 47():128208. PubMed ID: 34146702
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors.
Xu Y; Zhang XJ; Li WB; Wang XR; Wang S; Qiao XP; Chen SW
Eur J Med Chem; 2020 Dec; 208():112780. PubMed ID: 32883643
[TBL] [Abstract][Full Text] [Related]
9. The role of BPTF in melanoma progression and in response to BRAF-targeted therapy.
Dar AA; Nosrati M; Bezrookove V; de Semir D; Majid S; Thummala S; Sun V; Tong S; Leong SP; Minor D; Billings PR; Soroceanu L; Debs R; Miller JR; Sagebiel RW; Kashani-Sabet M
J Natl Cancer Inst; 2015 Feb; 107(5):. PubMed ID: 25713167
[TBL] [Abstract][Full Text] [Related]
10. Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening.
Zhang D; Han J; Lu W; Lian F; Wang J; Lu T; Tao H; Xiao S; Zhang F; Liu YC; Liu R; Zhang N; Jiang H; Chen K; Zhao C; Luo C
Bioorg Chem; 2019 May; 86():494-500. PubMed ID: 30780018
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a highly potent CECR2 bromodomain inhibitor with 7H-pyrrolo[2,3-d] pyrimidine scaffold.
Lu H; Lu T; Zu S; Duan Z; Guang Y; Li Q; Ma J; Chen D; Li B; Lu W; Jiang H; Luo C; Ye D; Chen K; Lin H
Bioorg Chem; 2022 Jun; 123():105768. PubMed ID: 35378372
[TBL] [Abstract][Full Text] [Related]
12. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
13. Selectivity, ligand deconstruction, and cellular activity analysis of a BPTF bromodomain inhibitor.
Kirberger SE; Ycas PD; Johnson JA; Chen C; Ciccone MF; Woo RWL; Urick AK; Zahid H; Shi K; Aihara H; McAllister SD; Kashani-Sabet M; Shi J; Dickson A; Dos Santos CO; Pomerantz WCK
Org Biomol Chem; 2019 Feb; 17(7):2020-2027. PubMed ID: 30706071
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
[TBL] [Abstract][Full Text] [Related]
15. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma.
Zhang C; Chen L; Liu Y; Huang J; Liu A; Xu Y; Shen Y; He H; Xu D
Theranostics; 2021; 11(8):3676-3693. PubMed ID: 33664855
[No Abstract] [Full Text] [Related]
16. Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening.
Zhang FC; Sun ZY; Liao LP; Zuo Y; Zhang D; Wang J; Chen YT; Xiao SH; Jiang H; Lu T; Xu P; Yue LY; Du DH; Zhang H; Liu CP; Luo C
Acta Pharmacol Sin; 2020 Feb; 41(2):286-292. PubMed ID: 31253937
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression.
Zhou B; Hu J; Xu F; Chen Z; Bai L; Fernandez-Salas E; Lin M; Liu L; Yang CY; Zhao Y; McEachern D; Przybranowski S; Wen B; Sun D; Wang S
J Med Chem; 2018 Jan; 61(2):462-481. PubMed ID: 28339196
[TBL] [Abstract][Full Text] [Related]
18. Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules.
Urick AK; Hawk LM; Cassel MK; Mishra NK; Liu S; Adhikari N; Zhang W; dos Santos CO; Hall JL; Pomerantz WC
ACS Chem Biol; 2015 Oct; 10(10):2246-56. PubMed ID: 26158404
[TBL] [Abstract][Full Text] [Related]
19. Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features.
Stankiewicz P; Khan TN; Szafranski P; Slattery L; Streff H; Vetrini F; Bernstein JA; Brown CW; Rosenfeld JA; Rednam S; Scollon S; Bergstrom KL; Parsons DW; Plon SE; Vieira MW; Quaio CRDC; Baratela WAR; Acosta Guio JC; Armstrong R; Mehta SG; Rump P; Pfundt R; Lewandowski R; Fernandes EM; Shinde DN; Tang S; Hoyer J; Zweier C; Reis A; Bacino CA; Xiao R; Breman AM; Smith JL; ; Katsanis N; Bostwick B; Popp B; Davis EE; Yang Y
Am J Hum Genet; 2017 Oct; 101(4):503-515. PubMed ID: 28942966
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-3666 inhibits lung cancer cell proliferation, migration, and invasiveness by targeting BPTF.
Pan L; Tang Z; Pan L; Tang R
Biochem Cell Biol; 2019 Aug; 97(4):415-422. PubMed ID: 30481052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
